SYNOVUS FINANCIAL CORP - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q2 2020$11,000
-71.1%
65
-80.4%
0.00%
-100.0%
Q1 2020$38,000
+216.7%
331
+206.5%
0.00%
Q4 2019$12,000
+140.0%
108
+66.2%
0.00%
Q1 2019$5,000
+25.0%
650.0%0.00%
Q4 2018$4,000
-20.0%
650.0%0.00%
Q3 2018$5,000
+25.0%
650.0%0.00%
Q2 2018$4,000650.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders